Asterion Cannabis Inc. (“Asterion” or the “Company”) and Asterion Australia Pty Ltd (“Asterion Australia”), the Company’s wholly-owned subsidiary, announces that Asterion Australia has entered into a strategic advisory services agreement with Mr. John Wagner, a Non-Executive Director of Wagners Holding Company Limited (ASX: WGN) (“Wagners”).
Asterion Cannabis Inc. (“Asterion” or the “Company”) and Asterion Australia Pty Ltd (“Asterion Australia”), the Company’s wholly-owned subsidiary, announces that Asterion Australia has entered into a strategic advisory services agreement with Mr. John Wagner, a Non-Executive Director of Wagners Holding Company Limited (ASX: WGN) (“Wagners”). Pursuant to the agreement, Mr. Wagner has been appointed as a Strategic Advisor to the Board of Directors of Asterion Australia and Asterion’s Chief Executive Officer.
Mr. Wagner is one of the co-founders of Wagners and has been involved with Wagners since its inception. He has been instrumental in developing Wagners into one of the leading construction materials producers in South East Queensland. Mr. Wagner is also the inaugural Chair of Darling Downs Tourism and was the inaugural chair of the Toowoomba and Surat Basin Enterprises.
Wagners had a significant role in assisting Asterion and Asterion Australia in securing the appropriate piece of land in Toowoomba, Australia on which to construct and house approximately 40 hectares (99 acres) of cutting-edge, secure, purpose-built greenhouses for the production of high-quality medicinal cannabis (the “Queensland Facility”).
Mr. John Wagner commented, “I am very pleased to support Asterion and its plans to develop a state of the art facility at Wellcamp Airport, it is an exciting opportunity and one that will bring many economic benefits to the region.”
Asterion’s Chairman and CEO, Mr. Stephen Van Deventer commented, “We are extremely pleased to have established a strong following of support from Wagners. They are globally recognized as one of Queensland’s largest construction materials and service providers who add value across several industries. Having John Wagner as an advisor will assist in fostering long-term and deeply-rooted community and strategic relationships for Asterion in Australia.”
Wagners is an Australian company focused on the production and sale of construction materials. Wagners is an innovative service provider and a producer of new generation building materials. From a foundation as an independently owned company nearly 30 years ago in Toowoomba, Australia, Wagners is now an ASX-listed operator in domestic and international markets and one of Queensland’s largest construction materials and mining services companies.
The Wagner family developed the Toowoomba Wellcamp Airport, the first public airport to be constructed in Australia in 50 years. It was built entirely with private money and completed in less than 20 months. Toowoomba Wellcamp Airport has become a thriving international airport and a regional international gateway.
In 2009, Wagners was acknowledged by the Premier of Queensland at the Smart Business Awards as the company that had made the most significant impact on regional Queensland in the state’s 150-year history. In 2018 Wagners was inducted into the Queensland Business Leaders Hall of Fame in recognition of their intrepid entrepreneurship in successfully completing highly challenging infrastructure projects nationally and internationally.
Celebrating 30 years of operations, Wagners is constantly striving for innovative, effective and economic solutions, when supplying for the construction and mining industry both within Australia and internationally.
Asterion is a Canadian medicinal cannabis company with operations in Australia, specializing in medical cannabis and is focused on becoming an industry leader in next-generation cannabis products. The Company is focused on the future of precision agriculture and aims to produce the highest quality of genetically uniform cannabis strains, at an affordable price.
The Company is led by a team of highly experienced executives with over 120 years of combined experience in medical cannabis, renewable energy, capital markets, and other highly relevant sectors across North America, Oceania, Europe, Africa and Asia.
On Behalf of the Board of Directors
“Stephen Van Deventer”
Chairman & Chief Executive Officer
For further information, please contact:
This news release contains forward-looking statements and forward-looking information (collectively, “forward-looking statements”) within the meaning of applicable Canadian and U.S. securities legislation, including the United States Private Securities Litigation Reform Act of 1995. All statements in this news release that are not purely historical are forward-looking statements and include statements regarding beliefs, plans, expectations and orientations regarding the future including, without limitation, the advisory services to be provided by John Wagner, the construction of the Queensland Facility, the Company’s anticipated business plans, and its prospect of success in executing its proposed plans. Often, but not always, forward-looking statements can be identified by words such as “will”, “plans”, “expects”, “may”, “intends”, “anticipates”, “believes”, “proposes”, “estimates” or variations of such words including negative variations thereof and phrases that refer to certain actions, events or results that may, could, would, might or will occur or be taken or achieved. Forward looking statements are based on certain assumptions regarding the Company, including that the Company will be able to obtain the financing and approvals needed to build the Queensland Facility and to carry out its planned future activities. Actual results could differ from those projected in any forward-looking statements due to numerous factors including, but not limited to, the inability of the Company and Asterion Australia to obtain the required approvals for the construction and operation of the Queensland Facility, execute its proposed business plans and obtain the financing required to carry out its planned future activities. Other factors such as general economic, market or business conditions or changes in laws, regulations and policies affecting the biotechnology or cannabis industry, changes in general economic conditions, changes in the financial markets and in the demand and market price for cannabis, and delays in obtaining governmental and regulatory approvals, may also adversely affect the future results or performance of the Company. These forward-looking statements are made as of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements. Although the Company believes that the statements, beliefs, plans, expectations, and intentions contained in this news release are reasonable, there can be no assurance that those statements, beliefs, plans, expectations, or intentions will prove to be accurate. Readers should consider all of the information set forth herein and should also refer to other periodic reports provided by the Company from time-to-time.
Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements.